Life Science Investing Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
Life Science Investing Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights
Blue Lagoon Completes Second Tranche of Private Placement - Crescat Capital, Phoenix Gold Fund and Nicola Mining Increase Their Positions.
Cizzle Brands Corporation Reports $5.64 Million in Net Sales in the First Half of its 2025 Fiscal Year